Last updated 2026-06-18
- Raised $3M funding round, Feb 2024
- Raised $1M funding round led by AION Labs, Feb 2023
Total raised
$4.0M
Last: 2024-02
Stage
Seed
Founded
2023
Headcount
11
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
DenovAI is developing foundational technology platforms that can design proteins de novo - completely from scratch. The company is starting the journey to design next generation therapeutics like high-affinity antibodies, small protein and peptide biologics, and diagnostic reporters - all tailored to bind to their specific targets.
Its AI-based platform for rapid de novo antibody discovery will design high-affinity binders to epitopes of choice, reduce the discovery process from months to days and broaden the scope of therapy to many more diseases. The platform for de novo protein design can design bespoke high-affinity binders for targets of choice – unlocking many applications in biologics and diagnostics.
Funding history · 2 rounds · $4.0M total
2024-02
$3.0M
Q&A
- What is DenovAI Biotech's primary focus?
- DenovAI Biotech is developing foundational technology platforms for de novo protein design, aiming to create next-generation therapeutics like high-affinity antibodies, small protein and peptide biologics, and diagnostic reporters.
- When was DenovAI Biotech founded?
- DenovAI Biotech was founded in January 2023.
- How much funding has DenovAI Biotech raised in total?
- DenovAI Biotech has raised a total of $4,000,000 USD.
- Which investors participated in DenovAI Biotech's February 2023 funding round?
- In February 2023, DenovAI Biotech secured $1,000,000 USD in a funding round led by.
- Which investor participated in DenovAI Biotech's February 2024 funding round?
- In February 2024, DenovAI Biotech raised $3,000,000 USD from Amiti Ventures.
- What is DenovAI Biotech's current employee count?
- DenovAI Biotech has an employee count in the 11-50 range.
- What is DenovAI Biotech's primary sector?
- DenovAI Biotech's primary sector is Health Tech & Life Sciences.
- What technologies does DenovAI Biotech utilize?
- DenovAI Biotech utilizes Artificial Intelligence, Biologicals, and Molecules in its operations.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceBiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Business model
B2B
Tags
pharmaceuticalsproteinsdiagnosticsartificial-intelligencebiotechnologyantibodies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | denovai.com/ |
|---|---|
| linkedin.com/company/93381246 |
Identifiers & details
| Founded | 2023-1 |
|---|---|
| Employees (exact) | 11 |
Radar intelligence
Web history (Wayback)
| Domain | denovai.com |
|---|